| CEO: | Stuart Ashman |
| CFO: | Manprit Singh Randhawa |
| Executive Director: | Simon Hewitson |
| Group Finance Director: | Emily Bertram |
| Independent Non-Executive Director: | Catherine Denise Prescott |
| Non-Executive Chairman: | Martin Braddock Hunt |
| Non-Executive Dir: | Danielle Bekker |
| Address: | The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF |
| Phone: | +44 191 495 7325 |
| Website: | http://www.skinbiotherapeutics.com |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB00BF33H870 |
| Currency | UK Pounds |
| Share Price | 17.00p |
| Change Today | 0.88p |
| % Change | 5.43 % |
| 52 Week High | 26.10 |
| 52 Week Low | 13.63 |
| Volume | 920,602 |
| Shares Issued | 258.78m |
| Market Cap | £43.99m |
| Beta | 0.18 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:40 | 22,911 @ 17.00p |
| 16:10 | 23,259 @ 17.18p |
| 15:58 | 20,000 @ 17.18p |
| 15:57 | 30,000 @ 17.18p |
| 15:44 | 265 @ 17.25p |
| CEO | Stuart Ashman |
| CFO | Manprit Singh Randhawa |
You are here: research